Delivery Order SPE2DB20D3103-SPE2DB25FM2V8
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,665.85 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream (60 gm) to support federal healthcare programs. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,886.13 firm fixed-price delivery order contract is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,623.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a 60-gram pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award is for the supply of OPZELURA 1.5% cream (60g) to the Defense Logistics Agency (DLA). The $6,153.92 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024, with a completion date of July 25, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical to...
This federal contract award, valued at $5,778.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a period of performance through October 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,276.75, is for the delivery of OPZELURA 1.5% Cream (60 GM). This appears to be a Firm Fixed Price Delivery Order contract, with an ultimate completion date of November 1, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.45 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a period of performance through January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,187.36 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a period of performance through January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $6,179.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $4,557.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of OPZELURA 1.5% cream, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 24, 2024, and is structured as a firm fixed-price agreement. The award is not associated with a set-aside designation, indicating open...